On Jun. 8, 2012, the U.S. Food and Drug Administration (FDA) announced that Genentech’s drug Perjeta (pertuzumab) was…
On May 25, 2012, Drs. Jennifer Doudna, Emanulle Charpentier, Martin Jinek of UC Berkeley and Krzystof Chylinski of…
On Apr. 30, 2012, Hologic announced the acquisition of San Diego-based Gen-Probe, a molecular diagnostics company, for $3.7…
On Apr. 24, 2012, the U.S. Department of Agriculture’s (USDA) Animal and Plant Health Inspection Service (APHIS) confirmed…
On Mar. 26, 2012, researchers at Stanford University School of Medicine reported study results that showed human tumors…
On Jan. 30, 2012, the U.S. Food and Drug Administration (FDA) approved Genentech’s Erivedge (vismodegib) capsule, the first…
In 2012, Ryan Phelan and Stewart Brand founded the Revive & Restore project within The Long Now Foundation,…
On Jan 1, 2012, renowned biochemist Michael A. Marletta became president and CEO of The Scripps Research Institute…
In 2012, The UC Davis Comprehensive Cancer Center received NCI comprehensive cancer designation. The center is a matrix…
In 2012, CALIBR, the California Institute for Biomedical Research (Calibr), was launched as a nonprofit translational research institute…
On Aug. 17, 2011, Genentech announced that Elborafﾮ (vemurafenib) was approved by the FDA for the treatment of…
On Aug. 17, 2011, Stanford/Packard scientists found new uses for existing drugs by mining gene-activity data banks. When…
On Aug. 16, 2011, the U.S. Food and Drug Administration (FDA) approved vemurafenib tablets (Zelboraf, Hoffmann-LaRoche Inc.) for…
On Mar. 28, 2011, the Priestley Medal was awarded to Ahmed H. Zewail by the American Chemical Society…
On Mar. 23, 2011, J. Craig Venter Institute researchers announced Single Virus Genomics, enabling the isolation and complete…
On Feb. 9, 2011, the University of California, San Francisco (UCSF) celebrated the official opening of the Ray…
On Feb. 9, 2011, Stanford researchers used skin cells from patients with a severe genetic heart defect to…
On Oct. 29, 2010, The Eli and Edythe Broad CIRM Center for Regenerative Medicine and Stem Cell Research…
On Jun. 21, 2010, the U.S. Supreme Court lifted a nationwide ban on cultivation of biotech alfalfa by…
On May 25, 2010, the consolidated Dorris Neuroscience Center was dedicated at the Scripps Research Institute. The new…
On May 7, 2010, Lawrence Livermore National Laboratory (LLNL) biologists and informatics experts announced the Lawrence Livermore Microbial…
On Apr. 29, 2010, Stanford University of researchers announced they had have used a healthy person’s complete genome…
On Jan. 27, 2010, scientists at the Stanford University School of Medicine announced they had succeeded in the…
On Jan. 11, 2010, the U.S. Food and Drug Administration (FDA) approved Genentech’s tocilizumab (Actemra) for the treatment…
On Oct. 5, 2009, Carol W. Greider won a share of the Nobel Prize in Physiology or Medicine…
On Sept. 24, 2009, the second Phase III HIV-1 vaccine trial, also known as RV144, that began in…
On Apr. 15, 2009, a novel influenza A virus (then referred to as ‘swine origin influenza A virus’)…
On Apr. 15, 2009, infection with the new influenza A virus (then referred to as ‘swine origin influenza…
On Apr. 1, 2009, the University of Southern California (USC) purchased Norris Cancer Hospital and University Hospital (now…
On Mar. 26, 2009, Roche completed its acquisition of Genentech for $46.8 billion pursuant to a short-form merger…